CurifyLabs emerged from a decade of research by Niklas Sandler Topelius at Åbo Akademi University, Finland. His investigation on modernizing extemporaneous drug manufacturing grabbed the attention of Charlotta Topelius, a successful entrepreneur, who recognized an opportunity to revolutionize manual compounding processes in pharmacies.

In 2021, CurifyLabs was established with a mission to digitize and simplify pharmacy compounding. As pet owners themselves, Charlotta and Niklas saw a need for a technology that could facilitate more effective and customized treatments for pets.

Since then, CurifyLabs has grown and assembled a team of experts in pharmaceutical formulation development, software engineering, and quality control. The company aims to revolutionize personalized medicine by bringing together skilled pharmaceutical developers, software engineers, and quality control specialists.

At CurifyLabs, we remain committed to providing solutions that enable optimal treatments for all patients.